Fakultna Nemocnica Trencín

Trencin 21 trials 7 recruiting

21 Registered trials

7 Currently recruiting

Organisation

Fakultna Nemocnica Trencín

Location

Trencin, Slovakia

Identifier

ORG-100040950

Address

Legionarska 28, 911 01, Slovakia

Departments

Department of Internal medicine
Eye Clinic
Infekčné oddelenie
Interne oddelenie
Neurology
Očná klinika
Očná klinika (Ophtalmology)
Oncological clinic
Oncology department
Onkologická klinika
Ophtalmology
Ophthalmological clinic

Clinical trials at this site (21)

Search interface

OCEAN(a)-PreEvent - Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction to Prevent first major cardiovascular Events Pending

2025-520554-11-00 Cardiovascular Disease 5
A clinical trial of EYE201/MK-8748 in people with macular degeneration (MK-8748-003) Recruiting

2025-524894-17-00 Neovascular age-related macular degeneration (NVAMD) 10 2026-06-22
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which has Spread and Caused Significant Body Weight Lo… Recruiting

2025-522093-36-00 Cancer cachexia 10 2026-05-20
Clinical Study to Compare Efficacy and Safety of AVT29 and Eylea HD in Participants with Diabetic Macular Edema Recruiting

2025-522231-34-00 Diabetic Macular Edema 5 2026-03-31
Study to Assess the Injection Burden, Safety, Efficacy, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec (ABBV-RGX-314) … Recruiting

2024-512298-28-00 Neovascular age-related macular degeneration 11 2025-12-18
A study to test whether BI 1815368 helps people with an eye condition called diabetic macular edema Recruiting

2024-520384-14-00 Centre-involved diabetic macular edema 4 2025-11-20
A Study to Learn About the Study Medicine Called PF-07248144 in Combination with Fulvestrant in People with HR-positive, HER2-negative Advan… Recruiting

2025-520566-22-00 Hormone Receptor-Positive, HER2-Negative Advanced/Metas 5 2025-11-10
A trial to learn how well baxdrostat with dapagliflozin works compared to dapagliflozin on clinical outcomes alone and how safe it is in adu… Recruiting

2023-506460-14-00 Chronic kidney disease (CKD) and hypertension. 5 2025-05-07
A randomized study to evaluate the Efficacy and Safety of Intravitreal EYE103 Compared to Anti-VEGF Ended

2025-520809-12-00 Diabetic Macular Edema 10 2025-10-16
A randomized study to evaluate the Efficacy and Safety of Intravitreal EYE103 Compared to Anti-VEGF (in patients with Diabetic Macular Edema… Ended

2024-510944-30-00 Diabetic Macular Edema 10 2024-11-22
A Phase 3 Placebo-controlled Study of Milvexian after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack Ended

2022-501176-26-00 Acute Ischemic Stroke and High-Risk Transient Ischemic 5 2023-08-04
A Randomised, Double-Blind, Phase III Study of AZD9833 plus Palbociclib versus Anastrozole plus Palbociclib in Patients with ER-Positive HER… Ended

2023-503995-26-00 Estrogen Receptor-Positive, HER2-Negative Advanced Brea 5 2021-05-11
Comparison of efficacy and safety of BP05 product and product of Lucentis in patients with Wet Age related Macular Degeneration Ended

2023-507459-31-03 wet macula degeneration 5 2024-05-22
Extension Study to Assess Batoclimab in Participants with TED. Ended

2024-512650-21-00 Thyroid Eye Disease (TED) 5 2023-12-13
A study to learn how well a higher amount of aflibercept given as an injection into the eye works and how safe it is in people with reduced … Ended

2022-502174-16-00 Macular edema secondary to retinal vein occlusion 5 2023-09-13
Phase 3 Study to Assess Batoclimab in Participants with Active Thyroid Eye Disease Ended

2024-512649-18-00 Thyroid Eye Disease 5 2023-06-05
Efficacy and Safety of AXL-Inhibitor bemcentinib for the Treatment of Moderate COVID-19 (AXL-SolidAct) Ended

2022-500363-12-00 SARS CoV-2 (COVID-19) 4 2022-08-24
A clinical study of OPT-302 with aflibercept compared to aflibercept alone in patients with neovascular age-related macular degeneration Ended

2024-512880-30-00 Neovascular Age-related Macular Degeneration (wet AMD) 5 2021-08-27
European DisCoVeRy for Solidarity: An Adaptive Pandemic and Emerging Infection Platform Trial (SolidAct) Ended

2022-500385-99-00 SARS-CoV II infection (Coronavirus disease) 5 2021-06-03
A Multicenter, Randomized, Double-Masked, Vehicle-Controlled Study to Assess the Safety and Efficacy of SYD-101 Ophthalmic Solution for the … Ended

2023-509134-19-00 Myopia 5 2019-10-23
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advan… Ended

2023-506487-13-00 Hormone receptor-positive, her2-negative advanced/metas 5